The use of technology in diabetes in pregnancy: a position statement of expert opinion from the association of medical diabetologists (AMD), the Italian society of diabetology (SID) and the interassociative diabetes and pregnancy study group

Nov 10, 2025Acta diabetologica

Expert recommendations on using technology to manage diabetes during pregnancy

AI simplified

GLP-1 Therapies on OpenScience ↗PubMed ↗DOI ↗OA ↗

Abstract

The number of women with diabetes during pregnancy has increased steadily over the last 10 years.

Maternal glycaemic control significantly influences both maternal and neonatal health outcomes.
Automated insulin delivery systems may improve management for women with type 1 diabetes during pregnancy.
Continuous glucose monitoring systems could enhance care for gestational diabetes and type 2 diabetes.
There is a need for improved knowledge regarding the availability of these advanced technologies among healthcare providers.
Current evidence and international guidelines are reviewed to inform the clinical use of these technologies in pregnancy.

AI simplified

Over the last 10 years, the number of women with diabetes during pregnancy has increased steadily. Maternal glycaemic control is the most important factor influencing maternal and neonatal outcomes, and technological advances have become integral to the evolution of diabetes care during pregnancy. However, rapid technological development must be accompanied by the equally rapid dissemination of information. In particular, knowledge of the availability of automated insulin delivery (AID) systems for managing type 1 diabetes in pregnancy, and of glucose continuous monitoring (CGM) systems for gestational and type 2 diabetes, needs to be increased. The AMD-SID Italian Diabetes and Pregnancy Study Group, supported by the Technology and Diabetes Study Group, has produced this position paper of expert opinion to review the main international guidelines and current evidence on new technologies for the management of pregnancy in women with GDM, type 1 and type 2 diabetes, and to provide detailed suggestions for the use of commercially available systems in clinical practice.

Full Text

Full text is available at the source.

View full text (PDF) ↗View full text (HTML) ↗

The use of technology in diabetes in pregnancy: a position statement of expert opinion from the association of medical diabetologists (AMD), the Italian society of diabetology (SID) and the interassociative diabetes and pregnancy study group

Abstract

Full Text

You found one interesting study. We’ll send the next 7.

what lands in your inbox each week:

Recent issues from the glp-1 therapies brief

Abstract

Full Text

Related papers

You found one interesting study. We’ll send the next 7.

what lands in your inbox each week:

Recent issues from the glp-1 therapies brief